de Vera A[au] - Search Results

Year	Number of Results
1982	1
1983	1
1991	1
1999	1
2001	1
2002	1
2003	1
2006	1
2007	1
2008	1
2009	1
2010	1
2011	1
2012	2
2013	1
2014	3
2015	2
2018	2
2019	5
2020	5
2021	2
2022	1
2023	0

1

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.

Cohen JA, Barkhof F, Comi G, Hartung HP, Khatri BO, Montalban X, Pelletier J, Capra R, Gallo P, Izquierdo G, Tiel-Wilck K, de Vera A, Jin J, Stites T, Wu S, Aradhye S, Kappos L; TRANSFORMS Study Group. Cohen JA, et al. Among authors: de vera a. N Engl J Med. 2010 Feb 4;362(5):402-15. doi: 10.1056/NEJMoa0907839. Epub 2010 Jan 20. N Engl J Med. 2010. PMID: 20089954 Free article. Clinical Trial.

2

Androgen Receptor Activity Is Associated with Worse Survival in Glioblastoma.

Fariña-Jerónimo H, de Vera A, Medina L, Plata-Bello J. Fariña-Jerónimo H, et al. Among authors: de vera a. J Integr Neurosci. 2022 Apr 22;21(3):86. doi: 10.31083/j.jin2103086. J Integr Neurosci. 2022. PMID: 35633167 Free article.

3

Sexual behaviour and poor hygiene are related to recent hepatitis a virus community outbreaks.

Hernández Bustabad A, Morales Arráez D, González A, de Vera A, Díaz-Flores F, Lecuona Fernández M, Gómez-Sirvent JL, Avellón Calvo A, Hernández-Guerra M. Hernández Bustabad A, et al. Among authors: de vera a. Rev Esp Enferm Dig. 2020 Jun;112(6):448-455. doi: 10.17235/reed.2020.6687/2019. Rev Esp Enferm Dig. 2020. PMID: 32450702 Free article.

4

Predictive factors for not undergoing RNA testing in patients found to have hepatitis C serology and impact of an automatic alert.

Morales-Arraez D, Alonso-Larruga A, Diaz-Flores F, García Dopico JA, de Vera A, Quintero E, Hernández-Guerra M. Morales-Arraez D, et al. Among authors: de vera a. J Viral Hepat. 2019 Sep;26(9):1117-1123. doi: 10.1111/jvh.13122. Epub 2019 Jun 2. J Viral Hepat. 2019. PMID: 31077515

5

Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosis.

Izquierdo G, O'Connor P, Montalban X, von Rosenstiel P, Cremer M, de Vera A, Sfikas N, Francis G, Radue EW, Kappos L. Izquierdo G, et al. Among authors: de vera a. Mult Scler. 2014 Jun;20(7):877-81. doi: 10.1177/1352458513513059. Epub 2013 Nov 30. Mult Scler. 2014. PMID: 24293455 Clinical Trial.

6

Development and validation of a Bayesian survival model for inclusion body myositis.

Capkun G, Schmidt J, Ghosh S, Sharma H, Obadia T, de Vera A, Risson V, Amzal B. Capkun G, et al. Among authors: de vera a. Theor Biol Med Model. 2019 Nov 7;16(1):17. doi: 10.1186/s12976-019-0114-4. Theor Biol Med Model. 2019. PMID: 31694651 Free PMC article.

7

Patients with suboptimal hepatitis B virus diagnostic characterization are at risk of liver fibrosis progression.

Morales-Arraez D, Diaz-Flores F, Alonso A, de Vera A, Jimenez A, Garcia Dopico JA, Quintero E, Hernández-Guerra M. Morales-Arraez D, et al. Among authors: de vera a. Eur J Gastroenterol Hepatol. 2020 Mar;32(3):426-432. doi: 10.1097/MEG.0000000000001527. Eur J Gastroenterol Hepatol. 2020. PMID: 31490418

8

Risk of liver fibrosis progression in patients with suboptimal diagnosis of hepatitis C virus infection.

Morales-Arraez D, Nieto Bujalance Y, Diaz-Flores F, de Vera A, Jiménez A, Garcia Dopico JA, Quintero E, Hernández-Guerra M. Morales-Arraez D, et al. Among authors: de vera a. Eur J Gastroenterol Hepatol. 2020 Apr;32(4):528-534. doi: 10.1097/MEG.0000000000001534. Eur J Gastroenterol Hepatol. 2020. PMID: 31490420

9

Recent and historical pollution legacy in high altitude Lake Marboré (Central Pyrenees): A record of mining and smelting since pre-Roman times in the Iberian Peninsula.

Corella JP, Sierra MJ, Garralón A, Millán R, Rodríguez-Alonso J, Mata MP, de Vera AV, Moreno A, González-Sampériz P, Duval B, Amouroux D, Vivez P, Cuevas CA, Adame JA, Wilhelm B, Saiz-Lopez A, Valero-Garcés BL. Corella JP, et al. Among authors: de vera av. Sci Total Environ. 2021 Jan 10;751:141557. doi: 10.1016/j.scitotenv.2020.141557. Epub 2020 Aug 14. Sci Total Environ. 2021. PMID: 32882549

10

Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo.

De Vera AA, Gupta P, Lei Z, Liao D, Narayanan S, Teng Q, Reznik SE, Chen ZS. De Vera AA, et al. Cancer Lett. 2019 Feb 1;442:91-103. doi: 10.1016/j.canlet.2018.10.020. Epub 2018 Nov 1. Cancer Lett. 2019. PMID: 30391357 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results